Page last updated: 2024-09-05

lenalidomide and Nerve Degeneration

lenalidomide has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beal, MF; Calingasan, NY; Hensley, K; Kiaei, M; Neymotin, A; Petri, S; Schafer, P; Stewart, C; Wille, E	1

Other Studies

1 other study(ies) available for lenalidomide and Nerve Degeneration

Article	Year
Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Experimental neurology, 2009, Volume: 220, Issue:1 Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Body Weight; Cell Survival; Cytokines; Disease Models, Animal; Humans; Immunologic Factors; Lameness, Animal; Lenalidomide; Mice; Mice, Transgenic; Motor Neurons; Nerve Degeneration; Spinal Cord; Survival Rate; Thalidomide; Treatment Outcome	2009

Article

Year

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.

Experimental neurology, 2009, Volume: 220, Issue:1

Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Body Weight; Cell Survival; Cytokines; Disease Models, Animal; Humans; Immunologic Factors; Lameness, Animal; Lenalidomide; Mice; Mice, Transgenic; Motor Neurons; Nerve Degeneration; Spinal Cord; Survival Rate; Thalidomide; Treatment Outcome

2009